文献速递临床免疫质量管理与危急值

甲状腺球蛋白抗体筛查后行质谱检测可节省成本并优化实验室利用

Thyroglobulin Antibody Screen Prior to Mass Spectrometry Provides Measurable Cost Savings and Optimal Laboratory Utilization.
PubMed 文献 · Am J Clin Pathol · 2017-01-01

该研究分析了超过15万份甲状腺球蛋白抗体(TgAb)和甲状腺球蛋白(Tg)检测订单,评估反射检测策略(仅TgAb阳性样本用LC-MS/MS)的利用与成本。未采用反射检测的LC-MS/MS订单中1663份同时单独检测TgAb,造成约17万美元潜在不必要成本。结论认为仅在必要时(如TgAb阳性)使用昂贵方法可显著节省成本。

要点

  • 反射检测策略(TgAb阳性才用LC-MS/MS)被89%的Tg订单采用。
  • 未采用反射检测的LC-MS/MS订单中1663份同时单独检测TgAb,潜在不必要成本约17万美元。

核心结论

  • 仅在TgAb阳性患者中使用LC-MS/MS检测Tg可显著节省成本并更经济地利用医疗资源。

研究设计与样本

  • 回顾性分析实验室超过150,000份TgAb和Tg检测订单,并从三家商业实验室获取平均标价。

主要发现

  • 未采用反射检测的LC-MS/MS订单中,1,663份同时单独检测TgAb,代表约170,000美元的潜在不必要成本(来自TgAb阴性样本)。

临床怎么用

  • 实验室可对Tg检测采用反射策略,仅TgAb阳性样本使用LC-MS/MS,以降低成本。
  • 应避免在已采用反射检测的订单中额外单独检测TgAb,减少不必要费用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods that allow accurate quantitation of thyroglobulin (Tg) in the presence of Tg antibodies (TgAbs) have recently become available. Due to cost differences between LC-MS/MS and immunoassay, some laboratories now offer a reflex test strategy that uses LC-MS/MS only for TgAb-positive samples. The goal of this study was to examine utilization of Tg testing strategies and cost savings. METHODS: Test ordering patterns were examined for over 150,000 orders for TgAb and Tg in our laboratory. The average list price was determined from three separate commercial laboratories offering this testing. RESULTS: Data showed that 89% of orders for Tg used the reflex test option, resulting in a savings of over $3 million compared with testing all samples by LC-MS/MS. Of the Tg by LC-MS/MS orders not using the reflex option, 1,663 also included a separate order for TgAb on the same patient sample, representing approximately $170,000 in potentially unnecessary costs from TgAb-negative samples. CONCLUSIONS: Identifying situations to use more expensive testing methods (eg, LC-MS/MS) only when necessary, such as for TgAb-positive patients, leads to considerable cost savings and a more economical use of valuable health care resources.

来源:Am J Clin Pathol,查看原文。版权归原作者所有。

引用

  1. Powers JL, Strathmann FG, Straseski JA, et al. Thyroglobulin Antibody Screen Prior to Mass Spectrometry Provides Measurable Cost Savings and Optimal Laboratory Utilization. Am J Clin Pathol. 2017. PMID: 28395053. doi:10.1093/ajcp/aqw228

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。